Trials / Terminated
TerminatedNCT03274973
Study to Assess Long-term Effectiveness of Zomacton® and Treatment Adherence in Patients With Growth Hormone Deficiency or Ullrich-Turner Syndrome
A Prospective Non-Interventional Study to Assess Long-term Effectiveness of Zomacton® and Factors Affecting Adherence in Patients With Growth Hormone Deficiency or Growth Retardation Due to Ullrich-Turner Syndrome
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 4 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Assessment of long-term effectiveness of ZOMACTON in treatment of Growth Hormone Deficiency or growth retardation due to Ullrich-Turner Syndrome and assessment of compliance and adherence, optionally with the aid of an electronic app or patient diary.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Zomacton | Injection |
Timeline
- Start date
- 2018-05-14
- Primary completion
- 2018-10-31
- Completion
- 2018-10-31
- First posted
- 2017-09-07
- Last updated
- 2018-12-13
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03274973. Inclusion in this directory is not an endorsement.